This content is machine translated Heart failure: ESC guideline update 2023 Treatment of HFmrEF – what’s new? The European Society of Cardiology (ESC) recently updated its guidelines. Consequently, based on the EMPEROR-Preserved and DELIVER trials, the use of SGLT-2 inhibitors is now recommended for all stages of…
